Net loss

Name: Viridian Therapeutics, Inc. Net loss by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Viridian Therapeutics, Inc.·Business Segments·1 segment·Rolls up to Net Income

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	-$86.91M	-$100.74M	-$34.6M	-$120.36M	-$104.9M
Total	-$86.91M	-$100.74M	-$34.6M	-$120.36M	-$104.9M

Business SegmentsView metric